Clinical Trial Update: Bortezomib in Treating Patients With Advanced Cancer and Liver Dysfunction [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial of bortezomib in patients with advanced cancer and liver dysfunction has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Liver Failure

Drugs mentioned

• Bortezomib (bortezomib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Hepatic Complications, Malignant Neoplasm | Phase 1 | Status: COMPLETED